Yingxian Sun

5.4k total citations · 1 hit paper
179 papers, 3.5k citations indexed

About

Yingxian Sun is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yingxian Sun has authored 179 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Cardiology and Cardiovascular Medicine, 49 papers in Molecular Biology and 34 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yingxian Sun's work include Blood Pressure and Hypertension Studies (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers) and Cardiovascular Health and Risk Factors (21 papers). Yingxian Sun is often cited by papers focused on Blood Pressure and Hypertension Studies (41 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (25 papers) and Cardiovascular Health and Risk Factors (21 papers). Yingxian Sun collaborates with scholars based in China, United States and Saint Kitts and Nevis. Yingxian Sun's co-authors include Xiaofan Guo, Liqiang Zheng, Shasha Yu, Naijin Zhang, Guozhe Sun, Xingang Zhang, Yintao Chen, Zhao Li, Hongmei Yang and Shilong You and has published in prestigious journals such as Circulation, Nature Medicine and Journal of the American College of Cardiology.

In The Last Decade

Yingxian Sun

176 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure

2023 150 citations Naijin Zhang, Ying Zhang et al. profile →

Peers

Yingxian Sun

CCM

EPIDE

EDM

PHEOH

Xiaoshu Cheng China

Rainer Malik Germany

Xiaofan Guo China

Xiaoling Wang United States

Tan Xu China

Jing Ma China

Dawn Waterworth United Kingdom

Alan B. Weder United States

Verena Zuber United Kingdom

Aladdin H. Shadyab United States

Xiaoshu Cheng China

Yingxian Sun

1.4k ×1.1

CCM

937 ×1.1

571 ×1.0

EPIDE

434 ×0.8

EDM

405 ×0.8

PHEOH

Citations per year, relative to Yingxian Sun Yingxian Sun (= 1×) peers Xiaoshu Cheng

Countries citing papers authored by Yingxian Sun

Since Specialization

Citations

This map shows the geographic impact of Yingxian Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingxian Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingxian Sun more than expected).

Fields of papers citing papers by Yingxian Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingxian Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingxian Sun. The network helps show where Yingxian Sun may publish in the future.

Co-authorship network of co-authors of Yingxian Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Yingxian Sun. A scholar is included among the top collaborators of Yingxian Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingxian Sun. Yingxian Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Xiaofan, Guangxiao Li, Pengyu Zhang, et al.. (2025). Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial. Journal of the American Heart Association. 14(6). e036820–e036820.

Geng, Danxi, et al.. (2025). Efficacy and safety of intensive antihypertensive strategy in patients with low diastolic blood pressure: a secondary analysis of a cluster randomised trial. Heart. heartjnl–2025.

He, Jiang, Chuansheng Zhao, Shanshan Zhong, et al.. (2025). Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nature Medicine. 31(6). 2054–2061. 2 indexed citations

Li, Zhi, Boquan Wu, Jie Chen, et al.. (2024). WWP2 protects against sepsis-induced cardiac injury through inhibiting cardiomyocyte ferroptosis. Journal of Translational Internal Medicine. 12(1). 35–50. 10 indexed citations

Chen, Shuxian, Yuanming Zou, Kexin Cai, et al.. (2023). The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. Basic Research in Cardiology. 118(1). 48–48. 40 indexed citations

Yu, Shasha, Bo Wang, Guangxiao Li, et al.. (2023). Habitual Tea Consumption Increases the Incidence of Metabolic Syndrome in Middle-Aged and Older Individuals. Nutrients. 15(6). 1448–1448. 4 indexed citations

Yu, Shasha, Xiaofan Guo, Guangxiao Li, Hongmei Yang, & Yingxian Sun. (2023). Influence of Snoring on the Incidence of Metabolic Syndrome: A Community-Based Prospective Cohort Study in Rural Northeast China. Journal of Clinical Medicine. 12(2). 447–447. 1 indexed citations

Zheng, Liqiang, Yani Wu, Yali Wang, et al.. (2022). Effect of Financial Incentives on Hypertension Control: A Multicenter Randomized Controlled Trial in China. Hypertension. 79(10). 2202–2211. 11 indexed citations

Zou, Yuanming, Dong Wang, Xinyue Huang, et al.. (2022). Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease. Cell Death Discovery. 8(1). 119–119. 21 indexed citations

10.

Li, Wenhang, Pengbo Wang, Zhao Li, et al.. (2022). Predictive Value of the Age, Creatinine, and Ejection Fraction (ACEF) Score in Cardiovascular Disease among Middle-Aged Population. Journal of Clinical Medicine. 11(22). 6609–6609. 1 indexed citations

11.

Zhang, Naijin, Ying Zhang, Wei Miao, et al.. (2022). An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage. Redox Biology. 50. 102238–102238. 26 indexed citations

12.

Zhang, Naijin, Ying Zhang, Boquan Wu, et al.. (2021). Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury. Redox Biology. 47. 102141–102141. 39 indexed citations

13.

Li, Guangxiao, Tan Li, Yanli Chen, et al.. (2021). Associations between aortic regurgitation severity and risk of incident myocardial infarction and stroke among patients with degenerative aortic valve disease: insights from a large Chinese population-based cohort study. BMJ Open. 11(8). e046824–e046824. 3 indexed citations

14.

Zhang, Ying, Shilong You, Saien Lu, et al.. (2020). WWP2 regulates SIRT1‐STAT3 acetylation and phosphorylation involved in hypertensive angiopathy. Journal of Cellular and Molecular Medicine. 24(16). 9041–9054. 18 indexed citations

15.

Xu, Jiaqi, Ying Zhang, Shilong You, et al.. (2020). Paired box 9 regulates VSMC phenotypic transformation, proliferation, and migration via sonic hedgehog. Life Sciences. 257. 118053–118053. 12 indexed citations

16.

You, Shilong, Ying Zhang, Jiaqi Xu, et al.. (2020). The Role of BRG1 in Antioxidant and Redox Signaling. Oxidative Medicine and Cellular Longevity. 2020. 1–12. 17 indexed citations

17.

Wan, Liu, Yingxian Sun, Guang Yu, et al.. (2020). Protective Effects on Hypoxia Reoxygenation Cardiomyocytes by GLP-1R Agonists via PI3K/AKT Signaling Pathway. International journal of gerontology. 14(3). 168–173. 2 indexed citations

18.

Wang, Haoyu, Zhao Li, Xiaofan Guo, et al.. (2018). Contribution of non-traditional lipid profiles to reduced glomerular filtration rate in H-type hypertension population of rural China. Annals of Medicine. 50(3). 249–259. 6 indexed citations

19.

Chen, Yintao, Xiaofan Guo, Guozhe Sun, et al.. (2018). Effect of serum electrolytes within normal ranges on QTc prolongation: a cross-sectional study in a Chinese rural general population. BMC Cardiovascular Disorders. 18(1). 175–175. 17 indexed citations

20.

Wang, Haoyu, Yintao Chen, Guozhe Sun, et al.. (2018). Validity of cardiometabolic index, lipid accumulation product, and body adiposity index in predicting the risk of hypertension in Chinese population. Postgraduate Medicine. 130(3). 325–333. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact